Symbols / INTS Stock $5.25 -0.47% Intensity Therapeutics, Inc.
INTS (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
Intensity Therapeutics, Inc., a late-stage clinical biotechnology company, engages in the provision of treatment for the regional and systemic nature of cancer relapse and metastasis in the United States. Its lead product candidate includes INT230-6, which is in Phase 3 clinical studies for the treatment of soft tissue sarcoma; and neoadjuvant and metastatic triple negative breast cancer which is in Phase 2 clinical trials. The company was incorporated in 2012 and is headquartered in Shelton, Connecticut.
Ratings
Current target
$5.25
Low
$12.00
High
$125.00
Mean
$41.50
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2025-08-20 | main | Benchmark | Speculative Buy → Speculative Buy | $2 |
| 2025-08-12 | up | Brookline Capital | Hold → Buy | $3 |
| 2025-01-13 | init | Alliance Global Partners | — → Buy | $9 |
| 2024-11-21 | reit | HC Wainwright & Co. | Buy → Buy | $5 |
| 2024-10-31 | init | HC Wainwright & Co. | — → Buy | $5 |
| 2024-07-11 | reit | Benchmark | Speculative Buy → Speculative Buy | $12 |
| 2024-05-16 | reit | Benchmark | Speculative Buy → Speculative Buy | $12 |
| 2024-03-21 | reit | Benchmark | Speculative Buy → Speculative Buy | $12 |
| 2023-11-14 | reit | Benchmark | Speculative Buy → Speculative Buy | $12 |
| 2023-08-24 | reit | Benchmark | Speculative Buy → Speculative Buy | $12 |
| 2023-07-18 | init | Benchmark | — → Speculative Buy | $12 |
- INTS Stock Price, Quote & Chart | INTENSITY THERAPEUTICS INC (NASDAQ:INTS) - ChartMill Fri, 24 Apr 2026 07
- Intensity Therapeutics Announces Reverse Stock Split - PR Newswire Fri, 13 Feb 2026 08
- Why Is Retail Going Gaga Over INTS Stocks Today? - MSN Sun, 26 Apr 2026 21
- Why Did INTS Stock Plummet 25% Today? - Stocktwits Fri, 13 Feb 2026 14
- INTS Stock Price and Chart — NASDAQ:INTS - TradingView Fri, 31 Oct 2025 07
- All You Need to Know About Intensity Therapeutics Inc. (INTS) Rating Upgrade to Buy - Yahoo Finance Mon, 15 Dec 2025 08
- Intensity Therapeutics (INTS) price target decreased by 11.32% to 57.29 - MSN Mon, 27 Apr 2026 07
- Intensity Therapeutics (INTS) Stock Analysis Report | Financials & Insights - Benzinga Wed, 15 Apr 2026 07
- Intensity Therapeutics, Inc. Announces Pricing of $4 Million Registered Direct Offering of Common Stock - PR Newswire Fri, 31 Oct 2025 07
- Intensity’s tumor-injection platform wins platinum biotech award - Stock Titan Wed, 15 Apr 2026 07
- Intensity Therapeutics (NASDAQ: INTS) boosts $60M at-the-market capacity - Stock Titan Mon, 23 Mar 2026 07
- Trial in aggressive breast cancer sees 44% fewer severe side effects - Stock Titan hu, 12 Mar 2026 07
- INTS (Intensity) reports slight Q4 2025 EPS miss, shares edge higher with no quarterly revenue posted. - Acquisition - Cổng thông tin điện tử tỉnh Tây Ninh hu, 23 Apr 2026 04
- Intensity Therapeutics (INTS) CEO receives 37,749-share stock bonus grant - Stock Titan Mon, 30 Mar 2026 07
- What's Going On With Intensity Therapeutics Stock Friday? - Benzinga Fri, 13 Feb 2026 08
Insider Transactions
Financials
Statement View
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Operating Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Operating Expense |
|
11.97
-27.81%
|
16.59
+99.36%
|
8.32
+10.19%
|
7.55
|
| Research And Development |
|
6.79
-35.36%
|
10.50
+119.31%
|
4.79
-6.74%
|
5.13
|
| Selling General And Administration |
|
5.19
-14.81%
|
6.09
+72.35%
|
3.53
+46.11%
|
2.42
|
| General And Administrative Expense |
|
5.19
-14.81%
|
6.09
+72.35%
|
3.53
+46.11%
|
2.42
|
| Salaries And Wages |
|
2.64
-2.69%
|
2.72
+118.58%
|
1.24
+76.31%
|
0.70
|
| Other Gand A |
|
1.87
-25.02%
|
2.50
+48.51%
|
1.68
+2.69%
|
1.64
|
| Total Expenses |
|
11.97
-27.81%
|
16.59
+99.36%
|
8.32
+10.19%
|
7.55
|
| Operating Income |
|
-11.97
+27.81%
|
-16.59
-99.36%
|
-8.32
-10.19%
|
-7.55
|
| Total Operating Income As Reported |
|
-11.97
+27.81%
|
-16.59
-99.36%
|
-8.32
-10.19%
|
-7.55
|
| EBITDA |
|
-11.97
+27.81%
|
-16.59
-62.07%
|
-10.23
-36.44%
|
-7.50
|
| Normalized EBITDA |
|
-11.97
+27.81%
|
-16.59
-108.07%
|
-7.97
-6.28%
|
-7.50
|
| EBIT |
|
-11.97
+27.81%
|
-16.59
-62.07%
|
-10.23
-36.44%
|
-7.50
|
| Total Unusual Items |
|
—
|
0.00
+100.00%
|
-2.26
|
0.00
|
| Total Unusual Items Excluding Goodwill |
|
—
|
0.00
+100.00%
|
-2.26
|
0.00
|
| Special Income Charges |
|
—
|
0.00
+100.00%
|
-2.26
|
0.00
|
| Other Special Charges |
|
—
|
—
|
2.26
|
—
|
| Net Income |
|
-11.61
+28.66%
|
-16.27
-54.37%
|
-10.54
-38.99%
|
-7.58
|
| Pretax Income |
|
-11.61
+28.66%
|
-16.27
-54.37%
|
-10.54
-38.99%
|
-7.58
|
| Net Non Operating Interest Income Expense |
|
0.18
-42.68%
|
0.31
+1552.63%
|
0.02
+123.75%
|
-0.08
|
| Interest Expense Non Operating |
|
—
|
0.00
-100.00%
|
0.30
+271.95%
|
0.08
|
| Net Interest Income |
|
0.18
-42.68%
|
0.31
+1552.63%
|
0.02
+123.75%
|
-0.08
|
| Interest Expense |
|
—
|
0.00
-100.00%
|
0.30
+271.95%
|
0.08
|
| Interest Income Non Operating |
|
0.18
-42.68%
|
0.31
-3.09%
|
0.32
+16100.00%
|
0.00
|
| Interest Income |
|
0.18
-42.68%
|
0.31
-3.09%
|
0.32
+16100.00%
|
0.00
|
| Other Income Expense |
|
0.19
+6100.00%
|
0.00
+100.13%
|
-2.24
-4762.50%
|
0.05
|
| Other Non Operating Income Expenses |
|
0.19
+6100.00%
|
0.00
-87.50%
|
0.02
-50.00%
|
0.05
|
| Tax Rate For Calcs |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-11.61
+28.66%
|
-16.27
-54.37%
|
-10.54
-38.99%
|
-7.58
|
| Net Income From Continuing Operation Net Minority Interest |
|
-11.61
+28.66%
|
-16.27
-54.37%
|
-10.54
-38.99%
|
-7.58
|
| Net Income From Continuing And Discontinued Operation |
|
-11.61
+28.66%
|
-16.27
-54.37%
|
-10.54
-38.99%
|
-7.58
|
| Net Income Continuous Operations |
|
-11.61
+28.66%
|
-16.27
-54.37%
|
-10.54
-38.99%
|
-7.58
|
| Normalized Income |
|
-11.61
+28.66%
|
-16.27
-96.57%
|
-8.28
-9.15%
|
-7.58
|
| Net Income Common Stockholders |
|
-11.61
+28.66%
|
-16.27
-37.14%
|
-11.86
-56.45%
|
-7.58
|
| Diluted EPS |
|
-8.56
+70.73%
|
-29.24
+15.25%
|
-34.50
+36.96%
|
-54.73
|
| Basic EPS |
|
-8.56
+70.73%
|
-29.24
+15.25%
|
-34.50
+36.96%
|
-54.73
|
| Basic Average Shares |
|
1.36
+143.83%
|
0.56
+61.40%
|
0.34
+148.77%
|
0.14
|
| Diluted Average Shares |
|
1.36
+143.83%
|
0.56
+61.40%
|
0.34
-34.22%
|
0.52
|
| Diluted NI Availto Com Stockholders |
|
-11.61
+28.66%
|
-16.27
-37.14%
|
-11.86
-56.45%
|
-7.58
|
| Insurance And Claims |
|
0.67
-23.34%
|
0.87
+43.75%
|
0.61
+710.67%
|
0.07
|
| Preferred Stock Dividends |
|
—
|
—
|
1.32
|
—
|
| Rent And Landing Fees |
|
—
|
—
|
—
|
0.14
|
| Rent Expense Supplemental |
|
—
|
—
|
—
|
0.14
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
14.10
+194.81%
|
4.78
-72.34%
|
17.30
+884.35%
|
1.76
|
| Current Assets |
|
12.71
+277.91%
|
3.36
-78.25%
|
15.46
+965.75%
|
1.45
|
| Cash Cash Equivalents And Short Term Investments |
|
11.92
+360.27%
|
2.59
-82.47%
|
14.78
+1026.22%
|
1.31
|
| Cash And Cash Equivalents |
|
11.92
+360.27%
|
2.59
-69.73%
|
8.56
+552.13%
|
1.31
|
| Cash Equivalents |
|
11.84
+447.41%
|
2.16
-73.60%
|
8.19
|
0.00
|
| Cash Financial |
|
0.09
-79.91%
|
0.43
+16.62%
|
0.37
-72.03%
|
1.31
|
| Other Short Term Investments |
|
—
|
0.00
-100.00%
|
6.22
|
0.00
|
| Receivables |
|
—
|
—
|
—
|
0.06
|
| Taxes Receivable |
|
—
|
—
|
—
|
0.02
|
| Prepaid Assets |
|
0.79
+1.94%
|
0.77
+12.35%
|
0.69
+992.06%
|
0.06
|
| Other Current Assets |
|
—
|
—
|
0.01
-92.11%
|
0.08
|
| Total Non Current Assets |
|
1.39
-1.97%
|
1.42
-22.45%
|
1.83
+498.37%
|
0.31
|
| Net PPE |
|
0.10
-21.31%
|
0.12
-17.01%
|
0.15
+5.76%
|
0.14
|
| Gross PPE |
|
0.10
-21.31%
|
0.12
-17.01%
|
0.15
+5.76%
|
0.14
|
| Other Properties |
|
0.10
-21.31%
|
0.12
-17.01%
|
0.15
+5.76%
|
0.14
|
| Non Current Prepaid Assets |
|
—
|
—
|
—
|
0.17
|
| Other Non Current Assets |
|
1.30
-0.15%
|
1.30
-22.92%
|
1.68
+908.38%
|
0.17
|
| Total Liabilities Net Minority Interest |
|
2.23
+19.30%
|
1.86
-54.88%
|
4.13
-75.48%
|
16.86
|
| Current Liabilities |
|
2.15
+22.28%
|
1.75
-55.67%
|
3.96
-41.94%
|
6.82
|
| Payables And Accrued Expenses |
|
1.31
-21.30%
|
1.67
-52.89%
|
3.55
+52.43%
|
2.33
|
| Payables |
|
0.58
-52.17%
|
1.22
-60.01%
|
3.05
+405.47%
|
0.60
|
| Accounts Payable |
|
0.58
-52.17%
|
1.22
-60.01%
|
3.05
+405.47%
|
0.60
|
| Current Accrued Expenses |
|
0.73
+61.95%
|
0.45
-9.42%
|
0.50
-71.06%
|
1.72
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
0.80
+1328.57%
|
0.06
-85.71%
|
0.39
|
—
|
| Current Debt And Capital Lease Obligation |
|
0.03
+10.71%
|
0.03
+40.00%
|
0.02
-99.55%
|
4.49
|
| Current Debt |
|
—
|
—
|
—
|
4.35
|
| Other Current Borrowings |
|
—
|
—
|
—
|
4.35
|
| Current Capital Lease Obligation |
|
0.03
+10.71%
|
0.03
+40.00%
|
0.02
-86.01%
|
0.14
|
| Total Non Current Liabilities Net Minority Interest |
|
0.08
-28.18%
|
0.11
-36.78%
|
0.17
-98.27%
|
10.04
|
| Long Term Debt And Capital Lease Obligation |
|
0.08
-28.18%
|
0.11
-20.29%
|
0.14
|
0.00
|
| Long Term Capital Lease Obligation |
|
0.08
-28.18%
|
0.11
-20.29%
|
0.14
|
0.00
|
| Other Non Current Liabilities |
|
—
|
—
|
0.04
+0.00%
|
0.04
|
| Preferred Securities Outside Stock Equity |
|
—
|
—
|
0.00
-100.00%
|
10.00
|
| Stockholders Equity |
|
11.88
+306.99%
|
2.92
-77.83%
|
13.16
+187.18%
|
-15.10
|
| Common Stock Equity |
|
11.88
+306.99%
|
2.92
-77.83%
|
13.16
+187.18%
|
-15.10
|
| Capital Stock |
|
0.00
|
0.00
-100.00%
|
0.00
|
0.00
|
| Common Stock |
|
0.00
|
0.00
-100.00%
|
0.00
|
0.00
|
| Preferred Stock |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Share Issued |
|
2.52
+317.33%
|
0.60
+10.31%
|
0.55
+4.66%
|
0.52
|
| Ordinary Shares Number |
|
2.52
+317.33%
|
0.60
+10.31%
|
0.55
+4.66%
|
0.52
|
| Additional Paid In Capital |
|
90.27
+29.50%
|
69.70
+9.46%
|
63.68
+170.33%
|
23.55
|
| Retained Earnings |
|
-78.39
-17.38%
|
-66.78
-32.20%
|
-50.52
-30.69%
|
-38.65
|
| Total Equity Gross Minority Interest |
|
11.88
+306.99%
|
2.92
-77.83%
|
13.16
+187.18%
|
-15.10
|
| Total Capitalization |
|
11.88
+306.99%
|
2.92
-77.83%
|
13.16
+187.18%
|
-15.10
|
| Working Capital |
|
10.56
+556.90%
|
1.61
-86.02%
|
11.51
+314.33%
|
-5.37
|
| Invested Capital |
|
11.88
+306.99%
|
2.92
-77.83%
|
13.16
+222.45%
|
-10.75
|
| Total Debt |
|
0.11
-20.29%
|
0.14
-12.66%
|
0.16
-96.48%
|
4.49
|
| Net Debt |
|
—
|
—
|
—
|
3.04
|
| Capital Lease Obligations |
|
0.11
-20.29%
|
0.14
-12.66%
|
0.16
+10.49%
|
0.14
|
| Net Tangible Assets |
|
11.88
+306.99%
|
2.92
-77.83%
|
13.16
+187.18%
|
-15.10
|
| Tangible Book Value |
|
11.88
+306.99%
|
2.92
-77.83%
|
13.16
+187.18%
|
-15.10
|
| Duefrom Related Parties Current |
|
—
|
—
|
—
|
0.05
|
| Preferred Stock Equity |
|
—
|
—
|
—
|
0.00
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-9.23
+39.34%
|
-15.22
-111.24%
|
-7.21
-31.55%
|
-5.48
|
| Cash Flow From Continuing Operating Activities |
|
-9.23
+39.34%
|
-15.22
-111.24%
|
-7.21
-31.55%
|
-5.48
|
| Net Income From Continuing Operations |
|
-11.61
+28.66%
|
-16.27
-54.37%
|
-10.54
-38.99%
|
-7.58
|
| Other Non Cash Items |
|
0.03
+144.83%
|
-0.06
-153.21%
|
0.11
-39.11%
|
0.18
|
| Stock Based Compensation |
|
2.00
-34.92%
|
3.07
+119.81%
|
1.40
+19.59%
|
1.17
|
| Operating Gains Losses |
|
—
|
—
|
2.26
|
—
|
| Change In Working Capital |
|
0.35
+117.64%
|
-1.97
-351.15%
|
-0.44
-157.60%
|
0.76
|
| Change In Prepaid Assets |
|
-0.01
-104.32%
|
0.30
+114.56%
|
-2.07
-4000.00%
|
0.05
|
| Change In Payables And Accrued Expense |
|
0.36
+115.87%
|
-2.27
-239.06%
|
1.63
+131.68%
|
0.70
|
| Change In Accrued Expense |
|
—
|
—
|
-0.20
|
0.00
|
| Change In Payable |
|
0.36
+115.87%
|
-2.27
-239.06%
|
1.63
+131.68%
|
0.70
|
| Change In Account Payable |
|
0.36
+115.87%
|
-2.27
-239.06%
|
1.63
+131.68%
|
0.70
|
| Change In Other Current Assets |
|
—
|
—
|
—
|
0.05
|
| Change In Other Current Liabilities |
|
—
|
—
|
—
|
-0.18
|
| Investing Cash Flow |
|
0.00
-100.00%
|
6.35
+205.50%
|
-6.02
|
0.00
|
| Cash Flow From Continuing Investing Activities |
|
0.00
-100.00%
|
6.35
+205.50%
|
-6.02
|
0.00
|
| Net Investment Purchase And Sale |
|
0.00
-100.00%
|
6.35
+205.50%
|
-6.02
|
0.00
|
| Purchase Of Investment |
|
0.00
+100.00%
|
-3.06
+79.70%
|
-15.05
|
0.00
|
| Sale Of Investment |
|
0.00
-100.00%
|
9.41
+4.21%
|
9.03
|
0.00
|
| Financing Cash Flow |
|
18.56
+540.14%
|
2.90
-85.83%
|
20.47
+809.87%
|
2.25
|
| Cash Flow From Continuing Financing Activities |
|
18.56
+540.14%
|
2.90
-85.83%
|
20.47
+809.87%
|
2.25
|
| Net Issuance Payments Of Debt |
|
—
|
0.00
-100.00%
|
0.23
-89.78%
|
2.25
|
| Issuance Of Debt |
|
—
|
0.00
-100.00%
|
0.23
-89.78%
|
2.25
|
| Short Term Debt Issuance |
|
—
|
0.00
-100.00%
|
0.23
-89.78%
|
2.25
|
| Net Short Term Debt Issuance |
|
—
|
0.00
-100.00%
|
0.23
-89.78%
|
2.25
|
| Net Common Stock Issuance |
|
20.32
+528.84%
|
3.23
-85.59%
|
22.43
|
0.00
|
| Proceeds From Stock Option Exercised |
|
0.06
-82.55%
|
0.32
+542.00%
|
0.05
|
0.00
|
| Net Other Financing Charges |
|
-1.82
-178.10%
|
-0.65
+70.76%
|
-2.23
|
—
|
| Changes In Cash |
|
9.33
+256.40%
|
-5.97
-182.36%
|
7.24
+324.48%
|
-3.23
|
| Beginning Cash Position |
|
2.59
-69.73%
|
8.56
+552.13%
|
1.31
-71.09%
|
4.54
|
| End Cash Position |
|
11.92
+360.27%
|
2.59
-69.73%
|
8.56
+552.13%
|
1.31
|
| Free Cash Flow |
|
-9.23
+39.34%
|
-15.22
-111.24%
|
-7.21
-31.55%
|
-5.48
|
| Change In Interest Payable |
|
—
|
—
|
-0.20
|
0.00
|
| Common Stock Issuance |
|
20.32
+528.84%
|
3.23
-85.59%
|
22.43
|
0.00
|
| Issuance Of Capital Stock |
|
20.32
+528.84%
|
3.23
-85.59%
|
22.43
|
0.00
|
| Net Preferred Stock Issuance |
|
—
|
—
|
—
|
—
|
| Preferred Stock Issuance |
|
—
|
—
|
—
|
—
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 42026-03-30 View
- 8-K2026-03-27 View
- 10-K2026-03-27 View
- 8-K2026-03-23 View
- 8-K2026-03-06 View
- 8-K2026-03-05 View
- 8-K2026-02-13 View
- 42026-01-05 View
- 42026-01-05 View
- 8-K2025-12-05 View
- 8-K2025-12-04 View
- 8-K2025-11-06 View
- 10-Q2025-11-06 View
- 8-K2025-10-31 View
- 8-K2025-10-23 View
- 8-K2025-09-10 View
- 8-K2025-08-12 View
- 8-K2025-08-07 View
- 10-Q2025-08-07 View
- 8-K2025-08-04 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|